1. Home
  2. DLPN vs HOTH Comparison

DLPN vs HOTH Comparison

Compare DLPN & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dolphin Entertainment Inc.

DLPN

Dolphin Entertainment Inc.

HOLD

Current Price

$1.46

Market Cap

19.1M

ML Signal

HOLD

Logo Hoth Therapeutics Inc.

HOTH

Hoth Therapeutics Inc.

HOLD

Current Price

$0.74

Market Cap

17.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLPN
HOTH
Founded
1996
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.1M
17.7M
IPO Year
2008
2018

Fundamental Metrics

Financial Performance
Metric
DLPN
HOTH
Price
$1.46
$0.74
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
21.6K
2.9M
Earning Date
05-15-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
77.87
29.69
EPS
N/A
N/A
Revenue
$56,699,389.00
N/A
Revenue This Year
$14.73
N/A
Revenue Next Year
$7.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
9.70
N/A
52 Week Low
$0.99
$0.49
52 Week High
$1.88
$2.12

Technical Indicators

Market Signals
Indicator
DLPN
HOTH
Relative Strength Index (RSI) 49.65 49.28
Support Level $1.45 $0.49
Resistance Level $1.65 $0.80
Average True Range (ATR) 0.07 0.05
MACD 0.01 0.01
Stochastic Oscillator 52.17 44.87

Price Performance

Historical Comparison
DLPN
HOTH

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).

Share on Social Networks: